Royalty Pharma Plc (RPRX)
38.67
-1.06
(-2.67%)
USD |
NASDAQ |
Dec 08, 16:00
39.00
+0.33
(+0.85%)
After-Hours: 07:19
Royalty Pharma EPS Diluted (Quarterly): 0.6654 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Denali Therapeutics, Inc. | -0.736 |
| Amgen, Inc. | 5.934 |
| Eli Lilly & Co. | 6.211 |
| Zenas BioPharma, Inc. | -1.222 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 444.21M |
| Revenue (Quarterly) | 609.29M |
| Total Expenses (Quarterly) | 321.07M |
| Enterprise Value | 27.74B |
| Gross Profit Margin (Quarterly) | 99.79% |
| Profit Margin (Quarterly) | 72.91% |
| Earnings Yield | 4.52% |
| Operating Earnings Yield | 6.92% |
| Normalized Earnings Yield | 4.750 |